SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIMONDI, Erika
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.343
AS - Asia 3.147
EU - Europa 1.894
SA - Sud America 498
Continente sconosciuto - Info sul continente non disponibili 189
AF - Africa 76
OC - Oceania 7
AN - Antartide 1
Totale 12.155
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.170
SG - Singapore 1.204
CN - Cina 729
IT - Italia 570
BR - Brasile 387
VN - Vietnam 349
DE - Germania 260
HK - Hong Kong 257
PL - Polonia 212
UA - Ucraina 178
GB - Regno Unito 174
TR - Turchia 135
BD - Bangladesh 102
FI - Finlandia 99
CA - Canada 96
FR - Francia 84
SE - Svezia 84
JP - Giappone 81
RU - Federazione Russa 74
IN - India 73
ID - Indonesia 65
AR - Argentina 41
MX - Messico 37
ZA - Sudafrica 33
NL - Olanda 31
ES - Italia 30
IQ - Iraq 28
BE - Belgio 20
VE - Venezuela 19
PK - Pakistan 18
MY - Malesia 17
CZ - Repubblica Ceca 15
EC - Ecuador 14
CO - Colombia 13
SA - Arabia Saudita 13
LT - Lituania 12
UZ - Uzbekistan 12
AT - Austria 11
AE - Emirati Arabi Uniti 10
KG - Kirghizistan 9
MA - Marocco 9
EG - Egitto 8
JM - Giamaica 8
RO - Romania 8
CL - Cile 7
KE - Kenya 7
AU - Australia 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
HN - Honduras 6
JO - Giordania 6
AZ - Azerbaigian 5
IL - Israele 5
TN - Tunisia 5
UY - Uruguay 5
CR - Costa Rica 4
DZ - Algeria 4
PH - Filippine 4
RS - Serbia 4
DK - Danimarca 3
HR - Croazia 3
IR - Iran 3
KR - Corea 3
NP - Nepal 3
PT - Portogallo 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
CH - Svizzera 2
CI - Costa d'Avorio 2
GE - Georgia 2
GP - Guadalupe 2
GR - Grecia 2
HU - Ungheria 2
IE - Irlanda 2
LB - Libano 2
LV - Lettonia 2
NI - Nicaragua 2
PE - Perù 2
PR - Porto Rico 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AQ - Antartide 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
DM - Dominica 1
ET - Etiopia 1
EU - Europa 1
GT - Guatemala 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
Totale 11.956
Salva come PNG Salva come JPEG
Città #
Ashburn 751
Singapore 725
Fairfield 533
San Jose 513
Woodbridge 487
Houston 283
Council Bluffs 278
Santa Clara 277
Beijing 257
Hong Kong 249
Seattle 231
Chandler 218
Warsaw 209
Ann Arbor 203
Dallas 203
Wilmington 198
Ferrara 191
Jacksonville 190
Cambridge 187
New York 132
Ho Chi Minh City 126
Los Angeles 116
Munich 80
Hanoi 78
Tokyo 76
Izmir 64
Princeton 59
Lauterbourg 54
Jakarta 53
Milan 53
São Paulo 48
Nanjing 47
San Diego 42
Shanghai 37
Helsinki 36
Boardman 35
Montreal 34
London 32
Buffalo 29
Bologna 28
Toronto 27
Chicago 26
Denver 25
Orem 25
Johannesburg 22
Chennai 21
Frankfurt am Main 20
Nanchang 20
Falls Church 19
Manchester 19
Atlanta 18
Rome 18
Boston 17
Brooklyn 17
Brussels 17
Da Nang 17
Hefei 17
Tianjin 17
Mexico City 16
Shenyang 16
Turku 16
Dearborn 15
Dong Ket 15
Poplar 15
Haiphong 14
Phoenix 14
San Francisco 14
The Dalles 14
Baghdad 13
Moscow 13
Rio de Janeiro 13
Ankara 12
Nuremberg 12
Tashkent 12
Bari 11
Ferrara di Monte Baldo 11
Lappeenranta 11
Washington 11
Brno 10
Stockholm 10
Auburn Hills 9
Bishkek 9
Campinas 9
Hebei 9
Jiaxing 9
Mumbai 9
San Mateo 9
Bremen 8
Caracas 8
Changsha 8
Charlotte 8
Columbus 8
Falkenstein 8
Guangzhou 8
Norwalk 8
Riyadh 8
Secaucus 8
Verona 8
Zhengzhou 8
Dhaka 7
Totale 8.258
Salva come PNG Salva come JPEG
Nome #
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 282
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 282
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 277
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 274
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 268
miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment 264
Serum Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Levels in Older Subjects with Dementia and Mild Cognitive Impairment 243
GM-CSF Exhibits Anti-Inflammatory Activity on Endothelial Cells Derived from Chronic Venous Disease Patients 235
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 233
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 226
Effects of intermittent pneumatic compression treatment on clinical outcomes and biochemical markers in patients at low mobility with lower limb edema 219
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy 219
Circulating TRAIL shows a significant post-partum decline associated to stressful conditions 218
Factors Predictive of Double Anterior Chamber Formation Following Deep Anterior Lamellar Keratoplasty 217
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells 213
MDM2 antagonist Nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts through a p53-dependent pathway 211
Involvement of TRAIL/TRAIL-receptors in human intestinal cell differentiation 210
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 208
A novel endovenous scaffold for the treatment of chronic venous obstruction in a porcine model: Histological and ultrastructural assessment 207
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 201
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 192
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 189
Human Colostrum and Breast Milk Contain High Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL). 188
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 187
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 187
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 185
Pegylated TRAIL retains anti-leukemic cytotoxicity and exhibits improved signal transduction activity with respect to TRAIL 182
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 180
Lower maternal serum tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) levels in early preeclampsia. A retrospective study 175
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 173
Sorafenib inhibits in vitro osteoclastogenesis by down-modulating Mcl-1 173
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 173
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 171
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 171
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 168
New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: recent advances 168
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 167
Role of vitamin D in the pathogenesis of atheromatosis 164
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 159
Soluble TRAIL does not impair the anti-osteoclastic activity of osteoprotegerin: Letter to the editor 152
Human collecting lymphatic glycocalyx identification by electron microscopy and immunohistochemistry 151
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL) 150
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 148
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 147
TRAIL Activates a Caspase 9/7-Dependent Pathway in Caspase 8/10-Defective SK-N-SH Neuroblastoma Cells with Two Functional End Points: Induction of Apoptosis and PGE2 Release 146
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 143
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside. 142
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 141
Synthesis and Biological Investigation of Bile Acid-Paclitaxel Hybrids 138
Levels of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Show a Long-term Stability in the Breast Milk of Mothers of Preterm Infants 137
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 128
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 126
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 125
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 112
Receptor activator of nuclear factor kappa B ligand (RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts 111
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 106
MitoQ is able to modulate apoptosis and inflammation 106
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 101
Ultrastructural Alterations of Grafted Corneal Buttons: The Anatomic Basis for Stromal Peeling Along a Natural Plane of Separation 98
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 92
null 92
The role of the mTOR pathway in diabetic retinopathy 91
null 90
null 90
null 88
null 86
null 83
Tumor necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. 76
null 76
NOVA2 expression in pituitary gland and in functioning and non-functioning pituitary adenomas: a preliminary study 70
null 69
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 67
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 67
TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF 63
null 55
null 44
null 42
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide 40
Towards defining the chemical signature of inflammatory skin conditions: an in vitro model 40
TOWARDS DEFINING THE CHEMICAL SIGNATURE OF INFLAMMATORY SKIN CONDITIONS USING VOLATILE METABOLITES: AN IN VITRO MODEL 39
Exploratory Volatilome Profiling of Inflammation in Skin Fibroblasts: A Proof-of-Concept Study 15
Analytical Profiling of Inflammation-associated Volatile Metabolites: HS-SPME to an in vitro model of Human Skin Fibroblasts 13
Totale 12.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.521
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.521
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022533 0 0 25 21 56 48 56 37 21 55 60 154
2022/2023523 58 32 23 59 77 74 34 46 71 2 29 18
2023/2024375 33 39 13 12 20 57 16 41 1 23 16 104
2024/20251.604 42 30 132 90 210 126 56 83 306 146 218 165
2025/20265.032 463 283 421 560 693 301 581 284 463 596 244 143
2026/2027521 129 250 142 0 0 0 0 0 0 0 0 0
Totale 12.155